Search is not available for this dataset
VAERS_ID int64 | RECVDATE string | STATE string | AGE_YRS float64 | CAGE_YR float64 | CAGE_MO float64 | SEX string | RPT_DATE string | SYMPTOM_TEXT string | DIED string | DATEDIED string | L_THREAT string | ER_VISIT string | HOSPITAL string | HOSPDAYS float64 | X_STAY string | DISABLE string | RECOVD string | VAX_DATE string | ONSET_DATE string | NUMDAYS float64 | LAB_DATA string | V_ADMINBY string | V_FUNDBY string | OTHER_MEDS string | CUR_ILL string | HISTORY string | PRIOR_VAX string | SPLTTYPE string | FORM_VERS int64 | TODAYS_DATE string | BIRTH_DEFECT string | OFC_VISIT string | ER_ED_VISIT string | ALLERGIES string |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2,728,969 | 01/01/2024 | AK | 14 | null | null | M | null | fluzone qiv hd administered to a minor patient with no reported adverse event; patient was supposed to receive the Flumist Nasal Spray but she grabbed the FLUZONE QIV HD and inadvertently gave it to intranasally with no reported adverse event; patient was supposed to receive the Flumist Nasal Spray but she grabbed the FLUZONE QIV HD and inadvertently gave it to intranasally with no reported adverse event; Initial information received from Regulatory Authority on 18-Dec-2023 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 14 years old male patient to whom influenza quadrival A-B high dose HV vaccine [Fluzone High-Dose Quadrivalent] was administered who was supposed to receive the Influenza Vaccine Live Reassort 3v (Flumist) nasal Spary but she grabbed the Fluzone QIV HD and inadvertently gave it to intranasally with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the minor patient received (dose 1) of 0.7 ml of suspect influenza quadrival A-B high dose HV vaccine, (lot 370679: formulation, strength and expiry date; unknown) via nasal route in unknown administration site for Immunization with no reported adverse event (product administered to patient of inappropriate age) (unknown latency). On an unknown date the was supposed to receive the flumist nasal spray but she grabbed the fluzone qiv hd and inadvertently gave it to intranasally with no reported adverse event (wrong product administered) (incorrect route of product administration) (unknown latency). This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. | null | null | null | null | null | null | null | null | U | null | null | null | null | UNK | null | null | null | null | null | USSA2023SA396019 | 2 | 12/30/2023 | null | null | null | null |
2,728,982 | 01/01/2024 | NJ | null | null | null | U | null | administering vaccines subcutaneously to patients; Reason for deletion: No GSK suspect | null | null | null | null | null | null | null | null | U | null | null | null | null | UNK | null | null | null | null | null | USGSKUS2023AMR179885 | 2 | 01/01/2024 | null | null | null | null |
2,728,984 | 01/01/2024 | null | null | null | null | U | null | extreme joint pain; Unable to walk; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of joint pain in a patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced joint pain (Verbatim: extreme joint pain) and unable to walk (Verbatim: Unable to walk). The outcome of the joint pain and unable to walk were not reported. It was unknown if the reporter considered the joint pain and unable to walk to be related to Arexvy. It was unknown if the company considered the joint pain and unable to walk to be related to Arexvy. Additional Information: GSK Receipt Date: 26-DEC-2023 This case was reported by a consumer via (Open field AE monitoring) interactive digital media. The patient reported that got extreme joint pain of almost unable to walk The reported that all symptoms except injection site pain. The patient reported that he/she scared badly. | null | null | null | null | null | null | null | null | U | null | null | null | null | UNK | null | null | null | null | null | USGSKUS2023AMR180978 | 2 | 01/01/2024 | null | null | null | null |
2,728,992 | 01/01/2024 | MO | null | null | null | F | null | was due to have 2nd when everything shut down for pandemic; This non-serious case was reported by a consumer via call center representative and described the occurrence of social problem in a 54-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose in 2019). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced social problem (Verbatim: was due to have 2nd when everything shut down for pandemic). The outcome of the social problem was unknown. Additional Information: GSK receipt date: 27-DEC-2023 The patient was due to have 2nd dose of Shingrix when everything shut down for pandemic (pandemic shutdown caused her to miss 2nd vaccine). The patient asked if she could still get 2nd shot or she should start series over? There was no information about having the 2nd shot years later There was no information regarding this gap. The patient stated that length of a gap was surprised by this because she could not be the only one affected that way. The patient stated that one pharmacist told her 2nd shot was not worthwhile, primary physician did not know what to advise. The patient asked, what is GlaxoSmithKline (GSK) advising to people with years since 1st vaccine? The patient thought that GSK needs to address this issue As the CDC had provided guidance that if it had been more than 6 months since a patient received the first dose, they should get the second dose as soon as possible; patients do not need to restart the vaccine series. The patient stated that, more than 6 months was very different than almost 4 years. The patient look forward to hearing more from the safety department. | null | null | null | null | null | null | null | null | U | null | null | null | null | UNK | null | null | null | null | null | USGSKUS2023AMR181463 | 2 | 01/01/2024 | null | null | null | null |
2,728,993 | 01/01/2024 | null | null | null | null | U | null | Injection site hot; Hypersentivity reaction; Chills/Shivering; cold and hot; temperature was 100.5; redness expanded and completely circled the entire am/Injection site redness; all around arm and very itchy/ itchy in the size for the golf ball; area of hardness was probably like the size of an orange or avocado; was a good sized lump/the lump in arm about the size of a golf ball now; Hives; This non-serious case was reported by a consumer via other manufacturer and described the occurrence of injection site warmth in a patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. Co-suspect products included Pneumococcal vaccine conj 20v (CRM197) (Prevnar 20) (expiry date 30-NOV-2024) for prophylaxis. Concurrent medical conditions included autoimmune disorder (Autoimmune disorder diagnosed in August 7 years ago) and immunosuppression. Concomitant products included azathioprine (Imuran). On 01-DEC-2023, the patient received Arexvy (right arm) and Prevnar 20 (right arm). On 01-DEC-2023, less than a day after receiving Arexvy, the patient experienced injection site warmth (Verbatim: Injection site hot), hypersensitivity reaction (Verbatim: Hypersentivity reaction), chills (Verbatim: Chills/Shivering), feeling hot and cold (Verbatim: cold and hot), fever (Verbatim: temperature was 100.5) and erythema of extremities (Verbatim: redness expanded and completely circled the entire am/Injection site redness). In DEC-2023, the patient experienced hives (Verbatim: Hives), itchy upper limbs (Verbatim: all around arm and very itchy/ itchy in the size for the golf ball), induration (Verbatim: area of hardness was probably like the size of an orange or avocado) and swelling arm (Verbatim: was a good sized lump/the lump in arm about the size of a golf ball now). The outcome of the injection site warmth, hypersensitivity reaction, chills, feeling hot and cold, fever, hives, erythema of extremities and induration were not reported and the outcome of the itchy upper limbs and swelling arm were not resolved. It was unknown if the reporter considered the injection site warmth, hypersensitivity reaction, chills, feeling hot and cold, fever, hives, erythema of extremities, itchy upper limbs, induration and swelling arm to be related to Arexvy. It was unknown if the company considered the injection site warmth, hypersensitivity reaction, chills, feeling hot and cold, fever, hives, erythema of extremities, itchy upper limbs, induration and swelling arm to be related to Arexvy. Additional Information: GSK receipt date: 20-DEC-2023 The patient self-reported this case. The patient was doing the math in head and this agent may be able to do the math faster. The reporter got the Prevnar 20 shot so and it was the first time had the pneumonia shot and also got the Arexvy RSV shot the same time in the same arm; had never had very little in the way of any kind of reaction to any kind of vaccine and thought did had a somewhat severe reaction for these and did not know which one it could be. The patient was also on Imuran as was immunosuppressed and was surprised had any reaction at all because immune system was suppressed. The patient did went on and do clinical research for 25 years so and was familiar with the process and was less concerned about the reaction and looked up both drugs for what happened and was already aware and the pharmacist mentioned these were one and done and never had to get a pneumonia vaccine again but if that was to change in the future was more concerned if was allergic to one ingredient and there was no way of knowing what ingredients might be sensitive to. The patient showed to the pharmacist his/her arm and they said definitely had a hypersensitive reaction for one of the vaccines and that if had the vaccine again it would be way worse and was trying to figure out what could possibly be sensitive to for one of these ingredients that might be more likely causing the adverse events. Reporter details were declined email. The health care professional (HCP) information, declined to provide information and stated did not see a physician and did call them and told them how was treating and they said fine and to keep doing that. The patient got the Prevnar 20 and the reaction started that evening, the reaction was in right arm. The patient did not get up to take temperature and woke up that night with chills, shivering and cold and hot and when finally, did get up in the morning took temperature and at that time was not shivering any longer and temperature was 100.5 and was making the assumption that temperature was higher than that to had the chills or any of that by the time took temperature. It had started out just as redness probably like a 2 inch by 2 inch area where the injection had gone in and it was hot. On Monday went back to the pharmacy by Monday and had hives and the area of redness expanded and completely circled the entire am and was about 2 hand widths for 6 to 8 inches wide all around arm and very itchy and red and the area of hardness was probably like the size of an orange or avocado and was a good sized lump and went to the pharmacist. The concern was not having this reaction but if needed the shot again what was going to happen and still had the lump in arm about the size of a golf ball now and itchy. The Arexvy vaccine and stated the manufacturer of that was GSK and it was given in the same arm and same location and did not think it was the Pfizer vaccine that bothered. The pharmacy gave the vaccine. The caller was asked for the dosage and dosage units and stated the app on phone lists the quantity of 0.5 but did not know what that was and did not had any other information on phone for the lot number. The reporter did not consent to follow up. | null | null | null | null | null | null | null | null | N | 12/01/2023 | 12/01/2023 | 0 | Test Name: Body temperature; Result Unstructured Data: (Test Result:100.5,Unit:unknown,Normal Low:,Normal High:) | UNK | null | Imuran | Autoimmune disorder (Autoimmune disorder diagnosed in August 7 years ago); Immunosuppression | null | null | USGSKUS2023AMR181703 | 2 | 01/01/2024 | null | null | null | null |
2,728,994 | 01/01/2024 | FL | null | null | null | M | null | muscle at the injection site is sore; He cannot lift anything more than 5 pounds.; Arm soreness; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site muscle pain in a adult male patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. Co-suspect products included Influenza vaccine for prophylaxis and Tozinameran (Pfizer BioNTech COVID-19 vaccine) for prophylaxis. On an unknown date, the patient received Arexvy (right arm), Influenza vaccine (left arm) and Pfizer BioNTech COVID-19 vaccine (left arm). On an unknown date, an unknown time after receiving Arexvy, the patient experienced injection site muscle pain (Verbatim: muscle at the injection site is sore), activities of daily living impaired (Verbatim: He cannot lift anything more than 5 pounds.) and pain in arm (Verbatim: Arm soreness). The outcome of the injection site muscle pain and activities of daily living impaired were not reported and the outcome of the pain in arm was unknown. It was unknown if the reporter considered the injection site muscle pain, activities of daily living impaired and pain in arm to be related to Arexvy. It was unknown if the company considered the injection site muscle pain, activities of daily living impaired and pain in arm to be related to Arexvy. Additional Information: GSK receipt date: 22-DEC-2023 Reporter was the patient. The patient was received a dose of AREXVY 4 months ago on his right arm and received a COVID-19 vaccine (Pfizer) and Flu vaccine (unknown manufacturer) on his left arm in the same visit. The patient states that the muscle at the injection site was sore. The patient cannot lift anything more than 5 pounds. The patient was an X ray done on his rotator cuff to see if it was the cause for soreness. The patient did not disclose results of exam. The reporter consented to follow up. | null | null | null | null | null | null | null | null | U | null | null | null | Test Date: 2023; Test Name: Xray of rotator cuff; Result Unstructured Data: (Test Result:not reported,Unit:unknown,Normal Low:,Normal High:) | PHM | null | null | null | null | null | USGSKUS2023179248 | 2 | 01/01/2024 | null | null | null | null |
2,728,995 | 01/01/2024 | CA | 11 | 11 | null | M | null | completed 5-series of Infanrix and was back for Boostrix booster; Infanrix was administered to a 11 y/o instead of Boostrix; Infanrix was administered to a 11 y/o; This non-serious case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 11-year-old male patient who received DTPa (Infanrix) (batch number 5H773, expiry date 13-JUL-2025) for prophylaxis. Previously administered products included Infanrix (received 1st dose on an unknown date), Infanrix (received 2nd dose on an unknown date), Infanrix (received 3rd dose on an unknown date), Infanrix (received 4th dose on an unknown date) and Infanrix (received 5th dose on an unknown date). On 18-DEC-2023, the patient received the 6th dose of Infanrix. On 18-DEC-2023, an unknown time after receiving Infanrix, the patient experienced extra dose administered (Verbatim: completed 5-series of Infanrix and was back for Boostrix booster), wrong vaccine administered (Verbatim: Infanrix was administered to a 11 y/o instead of Boostrix) and inappropriate age at vaccine administration (Verbatim: Infanrix was administered to a 11 y/o). The outcome of the extra dose administered, wrong vaccine administered and inappropriate age at vaccine administration were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 22-DEC-2023 The licensed practical nurse reported that the Infanrix vaccine was administered to a 11-year-old child instead of Boostrix, which led to wrong vaccine administered, extra dose administered and inappropriate age at vaccine administration. The patient had completed 5 series of Infanrix vaccine and was back for Boostrix booster. The reporter wanted to know could the Infanrix count as a completed series for the Boostrix. The reporter consented the follow up.up. | null | null | null | null | null | null | null | null | U | 12/18/2023 | 12/18/2023 | 0 | null | UNK | null | null | null | null | null | USGSKUS2023179249 | 2 | 01/01/2024 | null | null | null | null |
2,728,996 | 01/01/2024 | PA | 75 | null | null | F | null | patient received 3rd dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a 75-year-old female patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent 2023-2024 season) (batch number 23G34, expiry date 27-JUN-2024) for prophylaxis. Concomitant products included INFLUENZA VACCINE INACT SPLIT 4V (FLULAVAL QUADRIVALENT) and INFLUENZA VACCINE (INFLUENZA). On 26-DEC-2023, the patient received the 3rd dose of FluLaval Quadrivalent 2023-2024 season. On 26-DEC-2023, an unknown time after receiving FluLaval Quadrivalent 2023-2024 season and not applicable after receiving FLULAVAL QUADRIVALENT, the patient experienced extra dose administered (Verbatim: patient received 3rd dose). The outcome of the extra dose administered was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 26-DEC-2023 The reporter inquired about FluLaval and what information was available about the administration of extra doses of FluLaval, which led to extra dose administration. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up granted. | null | null | null | null | null | null | null | null | U | 12/26/2023 | 12/26/2023 | 0 | null | UNK | null | FLULAVAL QUADRIVALENT; INFLUENZA | null | null | null | USGSKUS2023180154 | 2 | 01/01/2024 | null | null | null | null |
2,728,997 | 01/01/2024 | null | null | null | null | U | null | The highest temperature reported in temperature excursion was 50°F; This non-serious case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in an unknown number of patients who received DTPa (Reduced antigen) (Boostrix) for prophylaxis. On an unknown date, the unspecified number of patients received Boostrix. On an unknown date, an unknown time after receiving Boostrix, the patients experienced incorrect storage of drug (Verbatim: The highest temperature reported in temperature excursion was 50°F). The outcome of the incorrect storage of drug was unknown. Additional Information: GSK receipt date:26-DEC-2023 The Nurse was called on 26th December 2023, to report on 8th September 2023 Boostrix vaccine was involved in a temperature excursion and was administered to an unknown number of patients. The reporter did not consent to follow up. | null | null | null | null | null | null | null | null | U | null | null | null | null | UNK | null | null | null | null | null | USGSKUS2023180157 | 2 | 01/01/2024 | null | null | null | null |
2,728,998 | 01/01/2024 | VA | 70 | null | null | F | null | Patient had 2nd dose of arexvy; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 70-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 2X7NA, expiry date 23-MAR-2025) and (batch number PK74B, expiry date 22-FEB-2025) for prophylaxis. Concomitant products included RSV VACCINE PROT. SUBUNIT PREF3 (AREXVY). On 26-DEC-2023, the patient received the 2nd dose of Arexvy. On 26-DEC-2023, an unknown time after receiving Arexvy and an unknown time after receiving AREXVY, the patient experienced extra dose administered (Verbatim: Patient had 2nd dose of arexvy). The outcome of the extra dose administered was unknown. Additional Information: GSK Receipt Date: 27-DEC-2023 Pharmacist requested guidance on how to proceed or what to expect with a patient who was administered Arexvy vaccine on 2nd December 2023 and a 2nd dose on 26th December 2023, which led to extra dose administered. The patient had not reported any side effects at the time of the call. The reporter consented to follow up. | null | null | null | null | null | null | null | null | U | null | 12/26/2023 | null | null | OTH | null | null | null | null | null | USGSKUS2023180758 | 2 | 01/01/2024 | null | null | null | null |
2,728,999 | 01/01/2024 | CA | null | null | null | M | null | second dose has not yet been given; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose in March 2022). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: second dose has not yet been given). The outcome of the incomplete course of vaccination was unknown. Additional Information: GSK receipt date: 28-DEC-2023 The pharmacist stated that a second dose of Shingrix had not yet been given to the patient. The reporter opted out of providing more information. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter did not consent to follow up. | null | null | null | null | null | null | null | null | U | null | null | null | null | UNK | null | null | null | null | null | USGSKUS2023181235 | 2 | 01/01/2024 | null | null | null | null |
2,729,000 | 01/01/2024 | TX | null | null | null | F | null | patient inadvertently received a dose of Bexsero instead of Menactra; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 16-year-old female patient who received Men B NVS (Bexsero) (batch number EN939, expiry date 31-OCT-2024) for prophylaxis. Previously administered products included Menactra (1st dose received on 08-AUG-2020). In DEC-2023, the patient received Bexsero. In DEC-2023, an unknown time after receiving Bexsero, the patient experienced wrong vaccine administered (Verbatim: patient inadvertently received a dose of Bexsero instead of Menactra). The outcome of the wrong vaccine administered was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 28-DEC-2023 The medical assistant stated that a patient inadvertently received a dose of Bexsero instead of Menactra this week (from the reporting date), which led to wrong vaccine administered. The reporter consented to follow up. | null | null | null | null | null | null | null | null | U | 12/01/2023 | 12/01/2023 | 0 | null | UNK | null | null | null | null | null | USGSKUS2023181248 | 2 | 01/01/2024 | null | null | null | null |
2,729,001 | 01/01/2024 | NJ | 17 | 17 | null | F | null | report that they have a patient that was administered with adacel intravenously with no reported adverse event; Initial information received on 15-Dec-2023 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 17 years old female patient who was administered with Diphtheria-2/Tetanus/5 AC Pertussis vaccine [Adacel] intravenously with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included cefradine (Ancef [cefradine]). On 14-Dec-2023, the patient received 0.5 ml dose (frequency: once; strength: standard) of suspect Diphtheria-2/Tetanus/5 AC Pertussis vaccine Suspension for injection of lot 2CA69C1 and Expiry: 20-Jul-2025 via IV NOS route in unknown administration site for immunization; with no reported adverse event (incorrect route of product administration) (latency: same day). This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. | null | null | null | null | null | null | null | null | U | 12/14/2023 | 12/14/2023 | 0 | null | UNK | null | ANCEF [CEFRADINE] | null | null | null | USSA2023SA394366 | 2 | 01/01/2024 | null | null | null | null |
2,729,002 | 01/01/2024 | NJ | null | null | null | U | null | one of those children received the diluent only rather than the actual vaccine with no reported adverse event; Initial information received on 19-Dec-2023 regarding an unsolicited valid non-serious case received via other health professional. This case involves Child and unknown gender patient and the reporter stated one of those children received the diluent only rather than the actual vaccine with no reported adverse event after receiving HIB (PRP/T) VACCINE [ACT-HIB]. The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided. On an unknown date, the patient received an unknown dose of suspect HIB (PRP/T) VACCINE, Powder and solvent for solution for injection (strength, lot number, expiry date: unknown) via unknown route in unknown administration site for immunization and one of those children received the diluent only rather than the actual vaccine with no reported adverse event (product preparation error) (latency: same day). Action Taken: Not applicable Outcome: Unknown Information on batch number was requested Reportedly, HCP reported that 4 ACTHIB vaccines were given. One of the children received diluent only. Therefore one child received no vaccine at all. Since they do not know which child received no vaccine, all 4 will be revaccinated so extra dose This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. | null | null | null | null | null | null | null | null | U | null | null | null | null | UNK | null | null | null | null | null | USSA2023SA397573 | 2 | 01/01/2024 | null | null | null | null |
2,729,003 | 01/01/2024 | MS | null | null | null | U | null | report that they administered fluzone qiv np intramuscular route (90 degree angle) as per pi but the thing is the needle that was used is for subcutaneous administration size with no ae; Initial information received on 26-Dec-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves an unknown age and unknown gender patient who experienced report that they administered influenza quadrival a-b vaccine [fluzone qiv] intramuscular route (90 degree angle) as per pi but the thing is the needle that was used is for subcutaneous administration size with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a 0.5 ml dose of suspect influenza quadrival a-b vaccine Suspension for injection (lot UT8091A, expiry date: 30-Jun-2024 with unknown strength) via intramuscular route in unknown administration site as Immunization (90 degree angle) as per pi but the thing is the needle that was used is for subcutaneous administration size with no adverse event (wrong technique in product usage process) (latency: same day). It was reported "They are asking what adverse effects to look out for and if the patient needs to be revaccinated." This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. | null | null | null | null | null | null | null | null | U | null | null | null | null | UNK | null | null | null | null | null | USSA2023SA403777 | 2 | 01/01/2024 | null | null | null | null |
2,729,004 | 01/01/2024 | MA | 61 | 60 | null | M | null | Micro-seizures starting approximately 2 weeks after 2nd dose given on 4/23/21. Seizures become more consistent resulting in a visit with primary care doctor and neurologist. An overnight stay was recommended on 06/23/21. Symptoms consisted of arrest in speech, eye rolling, arm stiffness. Micro-seizures happened about 5 times per hour and lasted for 5-8 seconds each time. Full seizure happened on 7/13/21, resulting in 4-day stay in the ICU. Pt. now takes 2 anti-seizure medications per day and 2 Rituximab infusions every 6 months (in-home). Lumbar puncture during ICU stay diagnosed him with the auto-immune disease called LGI1 Encephalitis. | null | null | null | null | null | null | null | Y | N | 04/02/2021 | 06/23/2021 | 82 | Hospital overnight observation tests, 06/23-06/24/2021: MRA, MRI, EEG / Test during 4-day ICU stay, 07/13-07/17/2021: Basic metabolic panel, CBC and differential, Glucose fingerstick, COVID-19 RT PCR, XR Chest, CT Anglo Head and without contrast, CT Head without contrast, Urine drug screen, MRSA/MSSA Pre-op PCR, Hepatic function panel, MRI Brain with and without contrast, Encephalitis panel, CSF, CSF culture, Cell count/differential, CSF, HSV (Herpes) I/II {CR, Varicella Zoster Virus DNA Quant Real time PCR, FL Lumbar Puncture | OTH | null | Lisinopril | None | Asthma | null | null | 2 | 01/01/2024 | null | Y | Y | Penicillin |
2,729,005 | 01/01/2024 | PA | 29 | 29 | null | F | null | 33w5d, due date 2/10/24 estimated birth weight 5 lbs. adverse event: severe muscle and joint aches (similar to aches usually associated with fever), redness and hardness at injection site. Painful and tender to the touch. Redness expanded on 12/30 and continued on 12/31 and 1/1 | null | null | null | null | null | null | null | null | N | 12/28/2023 | 12/29/2023 | 1 | null | PVT | null | Wellbutrin | null | null | null | null | 2 | 01/01/2024 | null | null | null | null |
2,729,006 | 01/01/2024 | RI | 58 | 58 | null | F | null | On September 14, 2023, I was admitted to Hospital with what turned out to be Endocarditis. The bacteria found from blood cultures was strep mitis. I was in the hospital for one week and continued with 5 and 1/2 weeks of iv penicillin G. When the course of antibiotics completed fever and chills came back. At that time, 10/31/2023, I went to another Hospital and was admitted. I was given more antibiotics and found that a spot on my lung had doubled in size. It is believed that the spot was infection but we never determined the exact bacteria. I was discharged on 11/8/2023 with a weeks worth of amoxicillin-clavulanate. A follow up ct scan of lungs on 12/24/2023 showed the lung spot had resolved. | null | null | Y | null | Y | 16 | null | null | Y | 12/12/2021 | 09/01/2023 | 628 | The hospitals have records of tests taken and the results. | PHM | null | No prescriptions. Only supplement taken was whey protein. | None. | None. | null | null | 2 | 01/01/2024 | null | null | null | None. |
2,729,007 | 01/01/2024 | DE | 60 | 60 | null | F | null | Fever ranging from 99.5 to 100.8 over a 12 hour period. | null | null | null | null | null | null | null | null | Y | 12/30/2023 | 12/31/2023 | 1 | None. | OTH | null | Atenolol (Tenormin), 50 mg. one each morning Paroxetine HCL (Paxil), 20 mg. one each morning Clopidogrel (Plavix), 75 mg. one each morning Apixaban (Eliquis), 5 mg. twice a day Rosuvastatin Calcium (Crestor), 40 mg. one each evening Repatha | None. | Atrial Fib, hypercholesteremia | null | null | 2 | 01/01/2024 | null | null | null | None. |
2,729,008 | 01/01/2024 | WI | 67 | 67 | null | F | null | Redness at the injection site. Starting day after injection and getting larger on day 4. She had dr visit via phone and was prescribed antibiotics for cellulitus | null | null | null | null | null | null | null | null | U | 12/28/2023 | 12/29/2023 | 1 | null | PHM | null | null | null | null | null | null | 2 | 01/01/2024 | null | Y | null | null |
2,729,009 | 01/01/2024 | NC | 72 | 72 | null | F | null | Patient had muscle tension in legs, profuse sweating and red rash around inject site that was the size of an adult hand. | null | null | null | null | null | null | null | null | Y | 12/29/2023 | 12/29/2023 | 0 | null | PHM | null | null | None | NKA | null | null | 2 | 01/01/2024 | null | null | null | NKA |
2,729,010 | 01/01/2024 | VA | 62 | 62 | null | M | null | 0300 12/30/23 Fever 102 degrees by oral thermometer, aches and pains, fatigue, chills, night sweats, diarrhea, loss of appetite. Fever broke 0900 12/31/23 fatigue, diarhea, loss of appetite continued for another 36 hours | null | null | null | null | null | null | null | null | Y | 12/29/2023 | 12/30/2023 | 1 | null | PHM | null | Metropolol, Metformin, Jardiance, Atorvastatin, Lisinopril, Melatonin, Glucosamine, Claritin | None | Type 2 Diabetes Mellitus without complication, no insulin, hypertension , obesity | null | null | 2 | 01/01/2024 | null | null | null | None |
2,729,011 | 01/01/2024 | OR | 67 | 67 | null | F | null | Incapacitating fatigue continuing for 14 days. Headache, nausea | null | null | null | null | null | null | null | null | N | 12/19/2023 | 12/19/2023 | 0 | null | PHM | null | atrovent, allegra, valsartan, advair, atenenlol | null | ABPA | null | null | 2 | 01/01/2024 | null | Y | null | NKDA |
2,729,012 | 01/01/2024 | null | 19 | 19 | null | M | null | Persistent headache; extreme soreness in arm for several days; inflammation around injection site, which grew larger each day, and eventually reached from the shoulder to the bend in the arm; symptoms cleared after a week | null | null | null | null | null | null | null | null | null | 12/13/2023 | 12/16/2023 | 3 | null | UNK | null | null | null | null | null | null | 2 | 01/01/2024 | null | Y | null | null |
2,729,013 | 01/01/2024 | FL | 68 | 68 | null | F | null | Left arm redness and lump near site of injection, red /rash under left armpit , aches in both calves- Under arm and legs are still painful on day 3 Note, if pain persists, will need to seek medical attention | null | null | null | null | null | null | null | null | N | 12/29/2023 | 12/29/2023 | 0 | no | PHM | null | amitriptyline 50 mg, Estradiol cream .01 %Fenofibrate 145 mg, metformin EX 500 mg , pioglitzone 15 mg, ramipril 25 mg, simvastatin 10 mg, Synroid 115 mg, Overcounter, Vitamins C, D3, , Canberry, Turmeric , CoQu 10 , Magnesium, Mannose D, | null | diabetic, high colestral = both under control with medications, thyroid | null | null | 2 | 01/01/2024 | null | null | null | null |
2,729,014 | 01/01/2024 | WA | 83 | 83 | null | F | null | patient's husband reported symptoms of prolonged shoulder pain. patient was seen by provider (PCP) and urgent care with no resolution from providers. | null | null | null | null | null | null | null | null | U | 11/20/2023 | 11/01/2023 | null | null | PHM | null | null | null | null | null | null | 2 | 01/01/2024 | null | Y | Y | null |
2,729,015 | 01/01/2024 | MD | 36 | 36 | null | F | null | Patient started experiencing hives and was prescribed prednisone 10mg by her Doctor | null | null | null | null | null | null | null | null | U | 11/28/2023 | 12/09/2023 | 11 | null | PHM | null | Zyrtec, Drosperinone-Ethynil Estradiol oral tablets, tretinoin | No | No | null | null | 2 | 01/01/2024 | null | Y | null | amoxicillin |
2,729,016 | 01/01/2024 | CA | 40 | 40 | null | F | null | Have developed lumps on my thighs and wrist and arm | null | null | null | null | null | null | null | null | N | 03/01/2019 | 07/01/2019 | 122 | null | UNK | null | No | No | No | null | null | 2 | 01/01/2024 | null | null | null | No |
2,729,017 | 01/01/2024 | VA | 56 | 56 | null | M | null | Lot number unclear on receipt. Here is all info: Spikevax 2023-24 Vial 50 mcg/0.5 ml inj. Covid-19 (Sars-Cov-2)Mrna VA. Reaction was that my brain was in a fog for the next week. Thinking was slowed, and took more effort than usual. This is distinctly different from my reaction to prior shots (4 of them), which were generally flu symptoms for about 24hrs. This was the first time my brain was affected. After about a week I perceived going back to normal, but I do not know if there are any lasting effects since it's hard to compare exactly. | null | null | null | null | null | null | null | null | Y | 10/13/2023 | 10/14/2023 | 1 | null | PHM | null | No meds. I consume ginger tea with turmeric daily as a supplement. | null | null | null | null | 2 | 01/01/2024 | null | null | null | null |
2,729,018 | 01/01/2024 | KY | 74 | 74 | null | F | null | fainted, fell and hit door, couldn't remember passing out, just clammy and hot and pale, paramedics came and checked her out and she left here on her own doing ok | null | null | null | null | null | null | null | null | Y | 01/01/2024 | 01/01/2024 | 0 | none | PHM | null | unknown | pt had just gotten over covid 2 weeks ago | none | null | null | 2 | 01/01/2024 | null | null | null | none |
2,729,019 | 01/01/2024 | NC | 0.92 | 0 | 1 | F | null | Fever 103-104; irritability, inconsolable; rash | null | null | null | null | null | null | null | null | Y | 12/06/2023 | 12/07/2023 | 1 | null | PVT | null | null | null | null | null | null | 2 | 01/01/2024 | null | Y | null | NKDA, No Known food or product allergies |
2,729,020 | 01/01/2024 | WA | 76 | 76 | null | M | null | patient complained of extreme pain on left arm. he went to the ER to get oxycodone for the pain. | null | null | null | null | null | null | null | null | U | 11/15/2023 | 11/01/2023 | null | null | PHM | null | null | null | null | null | null | 2 | 01/01/2024 | null | null | Y | null |
2,729,021 | 01/01/2024 | null | 49 | 49 | null | M | null | Patient is a 51 y.o. male patient of No, Physician with history of chronic respiratory failure s/p trach placement 8/17/2023, GERD, HTN presented on 11/13/2023 with shortness of breath and fevers. He was diagnosed with COVID. HMS consulted by MD for transfer to intermediate. He is discharged home in stable and improved condition on room air with supplies for tracheostomy care and referrals for ENT and urology. Patient updated on discharge plan and agrees. Acute on chronic respiratory failure?resolved Tracheostomy in place Status post trach placement 8/17/2023. Has a 5 Shiley extra long proximal cuffless On room air Patient not complaining of respiratory distress. Patient and his roommate educated on tracheostomy care Will need ENT follow up on discharge, referral sent Sepsis, on admission - resolved COVID 19 Pneumonia Hx of multiple mdr infections Aspiration pneumonitis/pneumonia Initial ED vitals showed mild tachycardia, afebrile, hypotensive. VSS, AF Improved VS, on TM not in any distress, feeling much better. Blood cultures,Urine antigens, MRSA probe neg.Initial lactic acid 0.8 COVID swab positive, isolation precautions started Given recent hospitalization with history of multidrug-resistant organisms, ID started on broad spectrum antibiotics. Procalcitonin negative, sputum culture NGTD, resp PCR NGTD Stop emperic abx. Completed Remdesivir dosing On Decadron 6mg daily x10 days for COVID-19 Noted elevated AST/ALT, may be related to remdesivir, appears to have plateaued and are now downtrending Remove COVID precautions 11/24 Urinary incontinence, reported States started after stay in select and long-term Foley Postvoid negative for urinary retention, unlikely overflow incontinence Trial oxybutynin Outpatient referral for urology Dysphagia Food noted in patient's trach tubing Speech recommends nectar thick liquids with puréed solids Continued SLP on discharge Patient educated again on diet Hypomagnesemia Replacement ordered HFpEF, without exacerbation Elevated Troponin BNP at 863, similar and reduced from prior Delta troponin flat, around patients baseline Echo 9/25/23: EF 60-65% Patient asymptomatic; no NTSEMI PEG tube Placed during prior hospitalization with tracheostomy Has not used PEG tube since discharge from nursing facility Tolerates p.o. intake Consulted general surgery for PEG tube removal. Patient did not want to have PEG tube removed after hearing about the process. Can follow-up about this outpatient. Info in AVS Left shoulder pain States has been told he has rotator cuff tear but c/o recent trauma prior to admission and now with left shoulder pain. Xray shoulder: Chronic separation of the left acromioclavicular joint, OP f/u Anxiety Continue home meds GERD Continue home meds | null | null | null | null | Y | 11 | null | null | null | 01/20/2022 | 11/13/2023 | 662 | null | UNK | null | null | null | null | null | null | 2 | 01/01/2024 | null | null | null | null |
2,729,022 | 01/01/2024 | TX | 66 | 66 | null | M | null | PATIENT SAYS HE HAS EXPERIENCE PAIN AND DISCOMFORT SINCE VACCINATION. HE HAS BEEN DOSING HIMSELF WITH OTC PAIN RELEIVERS. HE DESCRIBES THE PAIN AS CONSTANT BUT EXCRUCIATING IN THE EVENING HOURS , PROHIBITING HIM FROM GETTING RESTFUL SLEEP | null | null | null | null | null | null | null | null | N | 11/10/2023 | 11/10/2023 | 0 | NONE TO DATE | PHM | null | FLUZONE HD OPPOSITE ARM (LEFT) | PATIENT CLAIMS A VACCINE ISSUED AT DR OFFICE CAUSED PAIN TO LEFT ARM THAT STILL REMAINS TODAY. HE WAS UNABLE TO TELL ME WHAT VACCINE IT WAS. HE ALSO STATED HE WAS SENT TO THERAPY DUE TO THIS PAIN AND IS PENDING A COMPAINT AGAINST THE THERAPIST ASSIGNED TO HIM FOR PAIN MANAGEMENT BECAUSE HE WAS ALSO HURT DURING THERAPEAUTIC SESSION. | PATIENT CLAIMS TO BE IN CONSTANT PAIN OF HIS RIGHT ARM AND EXPAINS IT IS INTOLERABLE AT NIGHT AND PREVENTS HIM FROM RESTFUL SLEEP. | ACCORDING TO PATIENT YES .. DR NOT STATE ON FORM | null | 2 | 01/01/2024 | null | null | null | UNKNOWN TO PATIENT |
2,729,023 | 01/01/2024 | KS | 50 | 50 | null | F | null | Woke up next morning with a lot of floaters in my right eye. Couldn?t get into see dr for 3 weeks, he said my retina was thin but okay. Saw another opthamalogist 6 weeks later bc vision was impaired and he said I had a retinal tear in my eight eye and asked if I had any floaters recently and I said yes, at the end of May, the day after my covid vaccine. He said I?ve had this tear for a couple of months. That?s when I connected the dots between my vaccine and the retinal tear. I had a detached retina in my left eye when u was 26 yo, so I am prone to retinal tears. | null | null | null | null | null | null | null | null | Y | 05/19/2021 | 05/20/2021 | 1 | Saw Dr June 14, 2021 and he said the retina looked thin but didn?t appear to be torn. Then saw another Dr. with Vision Center for cataracts and he referred me to a third Dr. Saw Dr. August 12, 2021 and he did a lot of tests and looked very closely in my right eye and saw I had a retinal tear. He performed laser surgery August 17, 2021. | OTH | null | Vyvanse, Valacyclovir, minocycline, spironolactone, Claritin, women?s multivitamin gummies, Vitamin D, | None | None | null | null | 2 | 01/01/2024 | null | null | null | None |
2,729,024 | 01/01/2024 | null | 64 | 64 | null | F | null | Patient is a 66 y.o. female patient of CNP with history of hypertension hyperlipidemia diabetes mellitus also is known for nonobstructive coronary artery disease with congestive heart failure nonischemic cardiomyopathy with ejection fraction 30 to 35% improved up to 62 according to last echo history of obstructive sleep apnea with morbid obesity is here due to chest pain epigastric pain and weakness noticed to have COVID-positive on arrival to the emergency department and hypoxic with oxygen saturation in the mid 80s improved with nasal cannula at 2 L and elevated blood pressure chest image showed infiltrates COVID-19 respiratory infection Acute hypoxic respiratory failure Pneumonia due to COVID-19 Chest x-ray showed hazy airspace opacification at the right lung base which may represent pneumonia. We will place patient on oxygen therapy and telemetry continue supportive measures check inflammatory markers infectious disease consult was placed, start the patient on Decadron and remdesivir on room air and in no distress ; Will follow labs with ID Pt has had all immunizations prior to this Continue with Remdesivir and dexamethasone CT of chest with no sign of pneumonia 4mm right lower lung nodule is benign Remdesivir completed Room air If ok with Dr will discharge home today Chest pain - no complaints of - resolved Seem to be atypical and possible pleurisy related we will continue further trend of troponin levels and place patient telemetry Troponin negative; CT chest 11-19 negative Will order percocet prn for this complaint Hypertension resume home regimen Monitor the trend blood pressure was elevated on arrival, IV hydralazine as needed Diabetes mellitus We will monitor blood glucose and insulin sliding scale check A1c level Nonischemic cardiomyopathy Chronic CHF with preserved EF known for nonobstructive coronary artery disease with congestive heart failure nonischemic cardiomyopathy with ejection fraction 30 to 35% improved up to 62 according to last echo obstructive sleep apnea Resume CPAP while here Morbid obesity encourage healthier lifestyle | null | null | null | null | Y | 5 | null | null | null | 06/17/2022 | 11/17/2023 | 518 | null | UNK | null | null | null | null | null | null | 2 | 01/01/2024 | null | null | null | null |
2,729,025 | 01/01/2024 | CA | 54 | 54 | null | F | null | widespread pruritic vesicular rash consistent with varicella, followed by secondary bacterial infection right ear | null | null | null | null | null | null | null | null | N | 12/08/2023 | 12/10/2023 | 2 | 12/26/2023-VZV IgG 3137 Index Valuea-positive and VZV IgM- ISR1.66 high | PVT | null | estradiol .05mg/24 hr transdermal patch; progesterone 100mg daily | null | hyperlipidemia managed with lifestyle | null | null | 2 | 01/01/2024 | null | Y | null | codeine, sulfa |
2,729,026 | 01/01/2024 | null | 76 | 76 | null | F | null | Patient is a 77 y.o. female patient of DO with a PMHx of atrial fibrillation (on apixaban), breast cancer s/p mastectomy (over 30 years ago), HTN, GERD, osteoporosis, and diet-controlled DM2 admitted for COVID19 pneumonia. Acute hypoxic respiratory failure COVID19 pneumonia Sepsis POA secondary to COVID with tachycardia, hypoxia Date of onset of symptoms: 11/21/23 Symptoms present on admission: SOB, fatigue, HA, coughing Date of positive COVID19 test: 11/22/23 Imaging: CXR on admission negative for infiltrate --CTPA 11/22 neg for PE or infiltrate. Mild emphysema, bibasilar atelectasis noted. Oxygen requirements on admission: 2 L O2 on admit (none at baseline) Current oxygen requirements: RA Medical therapy: remdesivir, steroids, all started 11/22 - DuoNebs q6h while awake Stopped ROcephin/azithromycin 11/23 as no evidence of secondary bacterial infection Consultants following: None Anticipated special isolation end date: 12/02/23 RA am 11/23, able to walk in room but still significant tachycardia and exertional dyspnea + coughing fits, added mucinex, tessalon Much improved, tachycardia resolved, RA, walking around room without issue, cogh better Will discharge with short course decadron only secondary to rapid improvement and worsening GERD, DM Nonspecfic LAD on CT - has regular follow up with Dr with imaging PAF Remote DVT Continued home diltiazem and apixaban No evidence of RVR on admission Sinus tachycardia 11/23 , treat COVID Resolved, refill for cardizem ordered Essential HTN HLD Continued home lisinopril Continued home atorvastatin Diet controlled DM2 Hgb A1c 9/9/23 - 6.6% Carb consistent diet Sensitive sliding scale insulin ordered given risk of hyperglycemia while on steroids BG reasonable to date Short course steriods due to hyperglycemia and should resolve when off steriods GERD Takes prilosec OTC and will take BID at home until off steriods Does not need script | null | null | null | null | Y | 2 | null | null | null | 03/23/2023 | 11/22/2023 | 244 | null | UNK | null | null | null | null | null | null | 2 | 01/01/2024 | null | null | null | null |
2,729,027 | 01/01/2024 | IN | 27 | 27 | null | F | null | Numbness in my leg/foot two days afterwards. The numbness/tingling is non stop in my leg. | null | null | null | null | null | null | null | null | N | 12/28/2023 | 12/30/2023 | 2 | None | PVT | null | Magnesium | No | No | null | null | 2 | 01/01/2024 | null | null | null | None |
2,729,030 | 01/01/2024 | TN | 18 | 18 | null | F | null | Migraine, nausea, tachycardia, L leg pain and pulling (front of thigh, back of calf), heaviness of heart, SOB, irritability, fatigue, | null | null | null | null | Y | 1 | null | null | Y | 12/28/2023 | 12/29/2023 | 1 | Ultrasound, bloodwork, ekg, urine test | PVT | null | depakote, simplesse, Tylenol, multivitamin, famotidine, omeprazole, fish oil, D3 | none | bipolar, HS | null | null | 2 | 01/01/2024 | null | Y | Y | lamictal, adhesive, latex, red tip grass, |
2,729,031 | 01/01/2024 | OK | 37 | 37 | null | M | null | Had a massive heart attack on 03/25/2022 100% blockage in LAD | null | null | Y | null | Y | null | null | Y | N | 12/28/2020 | 03/25/2022 | 452 | null | PVT | null | None | None | None | null | null | 2 | 01/01/2024 | null | null | Y | Penicillin |
2,729,032 | 01/01/2024 | MN | 1 | 1 | 0 | F | null | Developed hives + fever 8 days following the vaccines, we were told to expect this. This lasted for 2 nights. On 8/7, we noticed that our child, who had just recently started walking about 2 weeks prior, seemed more off balance and wasn't walking as far. By 8/14, she had completely stopped walking and was actively avoiding putting weight on left lower extremity, holding limb off the floor and crying when she would stand. This prompted us to take her in to the Emergency Dept. She was diagnosed with toxic synovitis as an adverse reaction to the vaccine, and treated with over the counter NSAIDs (Motrin) 3 x per day x 1 week. Started walking and weightbearing on leg after 2 days of being on consistent anti-inflammatories. | null | null | null | null | null | null | null | null | Y | 07/28/2023 | 08/05/2023 | 8 | lower extremity x-rays, ultrasound imaging of hips bilaterally - performed at Hospital, results were unremarkable | PVT | null | null | none | none | null | null | 2 | 01/01/2024 | null | null | Y | none |
2,729,033 | 01/01/2024 | PA | 76 | 76 | null | F | null | Lack of appetite, welt at injection site 6 days later, left tonsil hurt, jaw hurt. Not sure which rsv shot it was | null | null | null | null | null | null | null | null | null | 12/26/2023 | 12/30/2023 | 4 | None | PHM | null | Cholesterol, blood pressure, calcium, tumeric | None | No | null | null | 2 | 01/01/2024 | null | null | null | None |
2,729,034 | 01/01/2024 | TX | 68 | 68 | null | M | null | 2-3 weeks after receiving the vaccine, developed dry mouth, chapped lips and irritation when eating (even non-spicy foods). Had poor hearing before vaccine and hearing loss got worse. loss of clarity in hearing words. | null | null | null | null | null | null | null | null | N | 10/04/2023 | 10/18/2023 | 14 | null | PHM | null | Amlodipine, Losartan | null | null | null | null | 2 | 01/01/2024 | null | Y | null | Erythromycin |
2,729,035 | 01/01/2024 | null | null | null | null | U | null | Redness, itchiness, skin hot to touch, left shoulder and bicep swelling by 7am the following day, Saturday. By 7am Sunday, under arm area on the left side was swollen. | null | null | null | null | null | null | null | null | N | null | null | null | null | UNK | null | null | null | null | January 2022 experienced swollen right bicep, redness, itchiness and skin hot to touch a few days after receiving booster | null | 2 | 01/01/2024 | null | null | null | null |
2,729,036 | 01/01/2024 | GA | 41 | 41 | null | M | null | A family of six came in for COVID vaccines. The father came in a few minutes late requesting COVID and flu vaccines. After preparation of vaccines, the family was brought into exam room. I was accompanied by another nurse to assist if needed. The identity of each family member was validated, and other pertinent information reviewed. The COVID vaccine was administered to one of the children, after which, the parents requested flu vaccines for the rest of the family. The other nurse went to prepare the vaccines at my request. Immediately after administration of the COVID vaccine to pt. it was discovered the he was inadvertently given the pediatric dose of the COVID vaccine. There were no symptoms and no treatment needed. | null | null | null | null | null | null | null | null | Y | 12/21/2023 | 01/01/2024 | 11 | None needed | PUB | null | None | None | HSV | null | null | 2 | 01/01/2024 | null | null | null | NKA |
2,729,037 | 01/01/2024 | HI | 63 | 63 | null | M | null | pt was presented to hospital 5 days after vaccination with hypertension crisis, NSTEMI, Acute kidney injury, COPD flare and anemia. | null | null | Y | null | Y | 3 | null | null | Y | 11/09/2023 | 11/14/2023 | 5 | null | PVT | null | null | none | CHF, CAD, aortic aneurysm, BPH, LBP | null | null | 2 | 01/01/2024 | null | null | null | none |
2,729,038 | 01/01/2024 | HI | 52 | 52 | null | M | null | found dead at home 9/27/23 | Y | 09/27/2023 | null | null | null | null | null | null | N | 09/19/2023 | 09/27/2023 | 8 | autopsy completed 10/31/23 showed dilated cardiomyopathy, mild CAD LAD and right coronary and left circumflex and aortic arch. | PVT | null | null | none | schizophrenia, HTN, obesity, sleep apnea | null | null | 2 | 01/01/2024 | null | null | null | risperidone - nausea |
2,729,039 | 01/02/2024 | TX | 43 | 43 | null | F | null | Redness, swelling, soreness at injection site and swollen lymph nodes in armpit. | null | null | null | null | null | null | null | null | N | 12/31/2023 | 12/31/2023 | 0 | null | PHM | null | Lipitor, vitamin d, Claritin, otc acid reflux med | Na | Allergies | Initial Pfizer Covid and 2021 TDAP vaccines | null | 2 | 01/02/2024 | null | null | null | Previous reaction to TDAP and initial Pfeizer vaccines |
2,729,044 | 01/02/2024 | VA | 67 | 67 | null | M | null | reports a patient could have received an incomplete dose of Arexvy; contained the adjuvant only and was not reconstituted; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 67-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number X7P97, expiry date 04-SEP-2026) for prophylaxis. On 27-DEC-2023, the patient received Arexvy (intramuscular). On 27-DEC-2023, an unknown time after receiving Arexvy, the patient experienced inappropriate preparation of medication (Verbatim: reports a patient could have received an incomplete dose of Arexvy) and inappropriate dose of vaccine administered (Verbatim: contained the adjuvant only and was not reconstituted). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown. Additional Information: GSK Receipt Date: 28-DEC-2023 The pharmacist reported that a patient could have received an incomplete dose of Arexvy. The reporter reported that patient could have received a dose of Arexvy that contained the adjuvant only and was not reconstituted, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter was uncertain if this patient received a complete dose or not. The reported consented to follow up. | null | null | null | null | null | null | null | null | U | 12/27/2023 | 12/27/2023 | 0 | null | UNK | null | null | null | null | null | USGSKUS2023181226 | 2 | 01/01/2024 | null | null | null | null |
2,729,045 | 01/02/2024 | AK | 66 | 66 | null | F | null | pediatric dose of Engerix-B was inadvertently given to an adult patient; pediatric dose of Engerix-B was inadvertently given to an adult patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of accidental underdose in a 66-year-old female patient who received HBV (Engerix B pediatric) (batch number 333M4, expiry date 07-APR-2024) for prophylaxis. On 16-DEC-2023, the patient received Engerix B pediatric. On 16-DEC-2023, an unknown time after receiving Engerix B pediatric, the patient experienced accidental underdose (Verbatim: pediatric dose of Engerix-B was inadvertently given to an adult patient) and adult use of a child product (Verbatim: pediatric dose of Engerix-B was inadvertently given to an adult patient). The outcome of the accidental underdose and adult use of a child product were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt date: 28-DEC-2023 Medical assistant stated that a pediatric dose of Engerix-B was inadvertently given to an adult patient, which led to accidental under dose and adult use child product. The vaccine administration facility was the same as primary reporter. The reporter consented to follow-up. | null | null | null | null | null | null | null | null | U | 12/16/2023 | 12/16/2023 | 0 | null | UNK | null | null | null | null | null | USGSKUS2023181240 | 2 | 01/02/2024 | null | null | null | null |
2,729,046 | 01/02/2024 | CA | null | null | null | U | null | medication error due to temp. excursion Max/low temperature reached: 1.2 C for 1 min not due to human error but ipol was administered post excursion with no reported adverse event; Initial information received on 20-Dec-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a patient of an unknown age and gender who had administered IPV (VERO) [IPOL] after exposed to temperature reached: 1.2 Celsius for 1 min not due to human error with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a unknown dose of suspect IPV (Vero) Suspension for injection (strength: unknown and expiry date: 02-Jun-2024, lot V1B901M via unknown route in unknown administration site as Immunization and due to temperature excursion reached: 1.2 Celsius for 1 min not due to human error with no reported adverse event (poor quality product administered) (same day latency). Reportedly: This is an excursion which happened last 14APR2023. Reason: The data logger incrementally got worse. Previous Excursion: No; Human error: No. The extended stability data was cover the excursion for the ADACEL and not for the punctured IPOL. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. | null | null | null | null | null | null | null | null | U | null | null | null | null | UNK | null | null | null | null | null | USSA2023SA401960 | 2 | 01/02/2024 | null | null | null | null |
2,729,048 | 01/02/2024 | null | null | null | null | U | null | viral sore; Covid-19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Covid-19) and VIRAL PHARYNGITIS (viral sore) in a patient of an unknown age and gender who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. In December 2023, the patient experienced COVID-19 (Covid-19). On 25-Dec-2023, the patient experienced VIRAL PHARYNGITIS (viral sore). At the time of the report, COVID-19 (Covid-19) and VIRAL PHARYNGITIS (viral sore) outcome was unknown. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Unknown) was unknown. No concomitant medication was reported. It was reported that patient had all of the Moderna vaccines The initial ones and the boosters and now patient had, actually, after three years patient had covid. But last night patient developed a viral sore, it was not raves but it's on the top of pallet on top of the teeth. No treatment medication was reported. Reporter did not allow further contact | null | null | null | null | null | null | null | null | U | null | 12/01/2023 | null | null | UNK | null | null | null | null | null | USMODERNATX, INC.MOD20237 | 2 | 01/02/2024 | null | null | null | null |
2,729,049 | 01/02/2024 | PR | 52 | 52 | null | M | null | null | null | null | null | null | null | null | null | null | N | 11/02/2021 | 11/02/2021 | 0 | null | PVT | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,050 | 01/02/2024 | PR | 80 | 80 | null | M | null | null | null | null | null | null | null | null | null | null | N | 11/02/2021 | 11/02/2021 | 0 | null | PVT | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,051 | 01/02/2024 | PR | 42 | 42 | null | F | null | null | null | null | null | null | null | null | null | null | Y | 11/02/2021 | 11/02/2021 | 0 | null | PVT | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,053 | 01/02/2024 | ME | 39 | 39 | null | M | null | Patient was given an Influenza vaccine vs the tetanus vaccine that was requested. Have made numerous attempts to contact patient to let him know. Unable to reach patient via phone. | null | null | null | null | null | null | null | null | U | 12/18/2023 | 12/18/2023 | 0 | null | PVT | null | Multivitamin, biotin, nutritional supplement | null | hyperlipidemia, anxiety, elevated blood pressure | null | null | 2 | 12/21/2023 | null | null | null | Egg protein, lactose |
2,729,135 | 01/02/2024 | PR | 82 | 82 | null | M | null | null | null | null | null | null | null | null | null | null | Y | 11/02/2021 | 11/02/2021 | 0 | null | PVT | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,136 | 01/02/2024 | PR | 55 | 55 | null | F | null | COMIRNATY VACCINE (PLASTIC TUBE) WAS ADMINISTERED ON 12/23/2023. THE VACCINE WAS RECEIVED ON 10/12/2023, THE 10 WEEKS WAS ON 12-20-2023, SO THE VACCINE WAS ADMINISTERED THREE DAYS AFTER THE 10 WEEKS. PATIENT WAS CONTACTED AND THE SITUATION WAS EXPLAINED. WE RECOMMENDED TO WAS CONTACT HER DOCTOR WHO KNOWS HER HEALTH PROFILE AND CAN DO A BETTER SUGGESTION IN REGARDS REVACCINATION OR NOT. SHE REPORTED ARM AND LOWER BACK PAIN FOR ONE DAY. | null | null | null | null | null | null | null | null | Y | 12/23/2023 | 12/01/2023 | null | NONE. | PHM | null | NO MEDICATIONS OR SUPPLEMENTS WERE REPORTED TO THE FACILITY. | NO ILLNESSES WERE REPORTED TO THE FACILITY. | NO CHRONIC HEALTH CONDITIONS WERE REPORTED TO THE FACILITY. | ARM AND LOWER PAIN | null | 2 | 01/02/2024 | null | null | null | NO ALLERGIES REPORTED TO THE FACILITY. |
2,729,137 | 01/02/2024 | PR | 69 | 69 | null | M | null | COMIRNATY VACCINE (PLASTIC TUBE) WAS ADMINISTERED ON 12/23/2023. THE VACCINE WAS RECEIVED ON 10/12/2023, THE 10 WEEKS WAS ON 12-20-2023, SO THE VACCINE WAS ADMINISTERED THREE DAYS AFTER THE 10 WEEKS. PATIENT WAS CONTACTED AND THE SITUATION WAS EXPLAINED. WE RECOMMENDED TO CONTACT HIS DOCTOR WHO KNOWS HIM HEALTH PROFILE AND CAN DO A BETTER SUGGESTION IN REGARDS REVACCINATION OR NOT. HE REPORTED ARM PAIN. | null | null | null | null | null | null | null | null | Y | 12/23/2023 | 12/01/2023 | null | NONE. | PHM | null | LOSARTAN 50MG, TRULICITY 4.5MG AND AMLODIPINE-ATORVASTATIN 10-40MG. | NO ILLNESSES WERE REPORTED TO THE FACILITY. | DIABETES, HIPERTENSION AND CHOLESTEROL. | ARM PAIN | null | 2 | 01/02/2024 | null | null | null | NO ALLERGIES WERE REPORTED TO THE FACILITY. |
2,729,138 | 01/02/2024 | PR | 57 | 57 | null | F | null | COMIRNATY VACCINE (PLASTIC TUBE) WAS ADMINISTERED ON 12/24/2023. THE VACCINE WAS RECEIVED AT THE PHARMACY ON 10/12/2023, THE 10 WEEKS FOR EXPIRATION WAS ON 12-20-2023, SO THE VACCINE WAS ADMINISTERED FOUR DAYS AFTER THE 10 WEEKS. PATIENT WAS CONTACTED AND THE SITUATION WAS EXPLAINED. WE RECOMMENDED TO CONTACT HER DOCTOR WHO KNOWS HER HEALTH PROFILE AND CAN DO A BETTER SUGGESTION IN REGARDS REVACCINATION OR NOT. SHE DIDN'T REPORTED ANY SIDE EFFECTS OR ADVERSE EVENT. | null | null | null | null | null | null | null | null | Y | 12/24/2023 | 12/01/2023 | null | NONE. | PHM | null | AMLODIPINE 2.5MG, FUROSEMIDE 20MG AND OMEPRAZOLE 20MG | NO ILLNESSES REPORTED TO THE FACILITY. | HIPERTENSION | null | null | 2 | 01/02/2024 | null | null | null | ASPIRIN |
2,729,139 | 01/02/2024 | MI | 84 | 84 | null | M | null | Admit date: 12/11/2023 Discharge date: 12/22/2023 Admitting Physician: MD Discharge Physician: MD Reason for Admission: COVID plus community-acquired pneumonia Hospital Course: Per note of DO: "Patient is a 86-year-old male with a past medical history of hypertension, type 2 diabetes mellitus prostate cancer with bone metastasis who presents with shortness of breath. Found to have COVID plus community-acquired pneumonia. Due to generalized worsening antibiotics broad to cefepime but was still having fevers and encephalopathy. Cefepime switched to Zosyn to see if this was contributing to encephalopathy. Fever resolved and AMS improving with switch to Zosyn, Lumbar puncture negative for meningitis. Neurology did not recommend any other testing. Possibly just COVID encephalitis vs hospital delirium. " Reportedly patient was found in bed cold and unresponsive about 45 minutes after being checked previously. CODE BLUE was called and CPR was initiated. Cardiac rhythm of asystole did not respond to three rounds of epinephrine. Time of death pronounced at 0525. Attempted to call wife; call directly went to voicemail; message left requesting wife to call the hospital. Procedures: MRI brain negative for acute illness LP not suggestive of meningitis Consults: Neurology Discharge Problem List * (Principal) Acute respiratory insufficiency Type 2 diabetes mellitus with hyperglycemia, without long-term current use of insulin COVID CAP (community acquired pneumonia) Acute encephalopathy Wt Readings from Last 1 Encounters: 12/21/23 82.1 kg (180 lb 14.4 oz) Discharged Condition: Deceased | Y | 12/22/2023 | null | null | null | null | null | null | null | 06/08/2022 | 12/11/2023 | 551 | null | PVT | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,140 | 01/02/2024 | MD | 62 | 62 | null | F | null | VACCINE FROZEN INSTEAD OF REFRIGERATED | null | null | null | null | null | null | null | null | null | 03/26/2022 | 03/26/2022 | 0 | null | PUB | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,142 | 01/02/2024 | IL | 48 | 48 | null | F | null | DO Last attending Treatment team Acute psychosis Discharge Summary DO (Resident) Emergency Medicine Cosigned by: DO at 12/25/2023 9:17 AM Attestation signed by, DO at 12/25/2023 9:17 AM I was physically present for the key or critical portions of the Evaluation and Management services performed by the resident. I personally evaluated and examined the patient. I participated and discussed the case with the resident and agree with the findings and the plan as documented in the resident's note. Discharge Summary Patient here for acute psychosis with dangerous delusions. Patient will be admitted to the hospitalist service for further evaluation with psychiatry on consult.Dr. will be on consult. Left Against Medical Advice | null | null | null | null | Y | 1 | null | null | null | 04/27/2021 | 12/24/2023 | 971 | null | PVT | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,143 | 01/02/2024 | DC | 64 | 64 | null | F | null | Vaccine frozen instead of refrigerated | null | null | null | null | null | null | null | null | null | 07/24/2020 | 07/24/2020 | 0 | null | PUB | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,144 | 01/02/2024 | null | 91 | 91 | null | M | null | Pt started feeling dizzy immediately after vaccine was given. BP 160/80. Diaphoretic. After 1 hour, pt was continuing to have the same side effects. Doctor referred to ER. Pt given BP medication at ER and sent home. Pt still feeling dizzy 4 days later. | null | null | null | null | null | null | null | null | U | 12/29/2023 | 12/29/2023 | 0 | null | PUB | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | Y | null |
2,729,145 | 01/02/2024 | MI | 78 | 78 | null | F | null | Admit date: 12/19/2023 Discharge date: 12/26/2023 Admitting Physician: MD Discharge Physician: MD Reason for Admission: syncope Discharge Problem List Acute cystitis without hematuria Syncope COVID-19 virus infection Epilepsy Hypothyroidism Chronic back pain CKD stage G3b/A1, GFR 30-44 and albumin creatinine ratio <30 mg/g (*) Gout Normocytic anemia Type 2 diabetes mellitus, without long-term current use of insulin (HCC) Procedures: None. Consultations: None Hospital Course: Patient had been feeling poorly for a week and reportedly had an episode of Syncope and had a ground level fall but apparently no significant injuries, some bruising. Syncope may have been from volume loss with poor oral intake and diarrhea that led to acute on chronic kidney injury with background of CKD stage G3b/A1, GFR 30-44. Improved with hydration and no further syncope. Found to have COVID-19 virus infection but has not been hypoxic so was not started on targeted therapy. Noted to have Acute cystitis without hematuria with culture growing. E.coli. Received three days of CEFTRIAXONE Epilepsy LEVETIRACETAM Hypothyroidism LEVOTHYROXINE Gout ALLOPURINOL no active disease Chronic back pain chronic pain medication Type 2 diabetes mellitus, without long-term current use of insulin on sliding scale Normocytic anemia likely of chronic disease. Discharge disposition: Rehab Facility / Unit | null | null | null | null | Y | 7 | null | null | null | 11/29/2021 | 12/19/2023 | 750 | null | PVT | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,146 | 01/02/2024 | DC | 66 | 66 | null | F | null | Vaccine frozen instead of refrigerated | null | null | null | null | null | null | null | null | null | 06/27/2022 | 06/27/2022 | 0 | null | PUB | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,147 | 01/02/2024 | PR | 57 | 57 | null | F | null | null | null | null | null | null | null | null | null | null | Y | 11/02/2021 | 11/02/2021 | 0 | null | PVT | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,148 | 01/02/2024 | FL | 61 | 61 | null | M | null | Flu-like symptoms. Platelet crash. | null | null | null | null | Y | 3 | null | null | Y | 12/08/2023 | 12/09/2023 | 1 | null | PHM | null | null | null | High glucose levels. | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,149 | 01/02/2024 | null | 80 | 80 | null | F | null | null | null | null | null | null | null | null | null | null | Y | 11/02/2021 | 11/02/2021 | 0 | null | PVT | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,150 | 01/02/2024 | OK | 1 | 0 | 1 | F | null | We did not give the vaccine but we were the urgent care facility to see the patient for the complication. She presented on December 24th for a rash on arm following a vaccine. | null | null | null | null | null | null | null | null | Y | 12/01/2023 | 12/24/2023 | 23 | Wound culture returned today and is positive for staph aureus. | UNK | null | none | none | none | null | null | 2 | 01/02/2024 | null | Y | null | none |
2,729,151 | 01/02/2024 | null | 59 | 59 | null | M | null | null | null | null | null | null | null | null | null | null | Y | 11/02/2021 | 11/02/2021 | 0 | null | PVT | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,153 | 01/02/2024 | ME | 78 | 78 | null | F | null | After 1 hour - developed 'shaking' throughout body like pt was freezing to death but was not cold. later developed into internal shaking lasting all day saturday 12/30. Went to urgent care Monday 1/1/24 * patient also reported back pain, mental deficits where saying wrong words or forgetfulness of details | null | null | null | null | null | null | null | null | Y | 12/29/2023 | 12/29/2023 | 0 | At Urgent care 1/1/24 - pt was monitored for 2 hours - Checked blood sugars, blood pressure, 3 EKGs, Was instructed to go to ER due to high blood pressure / and wanted to have additional monitoring completed at ER that was beyond capabilities of walk in care. Pt declined ER and went home to sleep 1/1/24 . | PHM | null | ASA 81 mg, Tylenol 650 mg , Losartan 100 mg, Spironolactone, Vitamin B-12 1000, Vitamin D | null | High Blood pressure | null | null | 2 | 01/02/2024 | null | Y | null | Chocolate with Soy letcin - diarrhea / Sensitive to dairy / Mangos |
2,729,154 | 01/02/2024 | DC | 69 | 69 | null | M | null | VACCINE FROZEN INSTEAD OF REFRIGERATED | null | null | null | null | null | null | null | null | null | 08/04/2021 | 08/04/2021 | 0 | null | PUB | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,155 | 01/02/2024 | null | 38 | 38 | null | M | null | null | null | null | null | null | null | null | null | null | Y | 11/02/2021 | 11/02/2021 | 0 | null | PVT | null | null | N/.A | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,156 | 01/02/2024 | DC | 71 | 71 | null | M | null | VACCINE FROZEN INSTEAD OF REGRIGERATED | null | null | null | null | null | null | null | null | null | 04/05/2023 | 04/05/2023 | 0 | null | PUB | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,157 | 01/02/2024 | PR | 62 | 62 | null | F | null | null | null | null | null | null | null | null | null | null | Y | 11/02/2021 | 11/02/2021 | 0 | null | PVT | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,158 | 01/02/2024 | NY | 75 | 75 | null | F | null | During the middle of the night, I was awakened by having trouble breathing. It was occurring in my upper throat. I would describe it as moderately severe; I was about to call EMS but I didn't. It resolved in approximately 20 mins. No additional adverse reaction noted. | null | null | null | null | null | null | null | null | Y | 12/08/2023 | 12/09/2023 | 1 | null | PHM | null | hydro chloro thiaz CAP 12.5 mg 1/day, Verapamil tab 120mg 1/daily, Propranolol tab 10mg 2/day, Buspirone tab 15mg 3/day, omeprazole DR CAP 20mg 1/day, Sertraline HCL tab 50 ml 1/day, Bupropionxl tab 150 mg 3/day, | None | High Blood Pressure, Depression, Anxiety. | null | null | 2 | 01/02/2024 | null | null | null | None |
2,729,159 | 01/02/2024 | null | 25 | 25 | null | F | null | Arm is sore for about a month and continuing to be sore when touched or lifted. | null | null | null | null | null | null | null | null | N | 12/04/2023 | 12/06/2023 | 2 | null | PVT | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,160 | 01/02/2024 | MI | 81 | 81 | null | M | null | Admit date: 12/25/2023 Discharge date: 12/26/2023 Admitting Physician: MD Discharge Physician: MD Admission Diagnoses: Hypoxia [R09.02] Pneumonia due to COVID-19 virus [U07.1, J12.82] Acute respiratory insufficiency [R06.89] Discharge Diagnoses: Principal Problem: Acute respiratory insufficiency Active Problems: COVID-19 virus infection Type 2 diabetes mellitus with cardiac complication Essential hypertension, benign Mixed hyperlipidemia Coronary artery disease of native artery of native heart with stable angina pectoris Parkinson's disease Artificial pacemaker Compulsive behavior disorder Mild episode of recurrent major depressive disorder Chronic combined systolic and diastolic heart failure Thrombocytosis Hyperbilirubinemia Hypoxia Fever Admission Condition: poor Discharged Condition: good Indication for Admission: Hypoxemia Hospital Course: Elderly man with Parkinson's disease presents with malaise cough and generalized weakness and on ER evaluation found to have mild hypoxemia and fever and COVID positive. Patient corrected with NC oxygen and was admitted and treated with steroids and oxygen. He rapidly improved and weaned to room air. He improved and requested discharge to home. CXR was unremarkable. Referred to home care for follow up of COVID and hypoxemia. | null | null | null | null | Y | 1 | null | null | null | 10/19/2022 | 12/25/2023 | 432 | null | PVT | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,161 | 01/02/2024 | DC | 65 | 65 | null | F | null | VACCINE FROZEN INSTEAD OF REFRIGERATED | null | null | null | null | null | null | null | null | null | 06/14/2023 | 06/14/2023 | 0 | null | PUB | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,162 | 01/02/2024 | PR | 55 | 55 | null | M | null | null | null | null | null | null | null | null | null | null | Y | 11/02/2021 | 11/02/2021 | 0 | null | PVT | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,163 | 01/02/2024 | IL | 76 | 76 | null | F | null | Admit date: 12/22/2023 Discharge date: 12/26/2023 Admitting Physician: MD Attending Physician at the Time of Discharge: DO Primary Care Physician: No primary care provider on file., None Reason for Admission: Acute hypoxic respiratory failure in the setting of COVID-19 infection Hospital Course: 79-year-old female with past medical history significant for hypertension, hyperlipidemia, anxiety, diabetes mellitus type 2 with long term insulin use, chronic pain with long-term opioid use who presented to emergency department on 12/22 with worsening symptoms of debility, nausea, vomiting, shortness of breath in the setting of COVID-19 infection. During the admission patient completed a short course of remdesivir, she was also started on dexamethasone. Due to the hypoxic respiratory failure patient required oxygen supplementation throughout most of her stay, up to 2 L oxygen via nasal cannula. On the day of discharge, patient was able to be weaned off oxygen. Ambulation test revealed patient is saturating well at 94% on room air. Symptoms improved significantly prior to discharge, she is being discharged in 12/26 in stable condition. Discharged to home. | null | null | null | null | Y | 4 | null | null | null | 04/19/2021 | 12/22/2023 | 977 | null | PVT | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,164 | 01/02/2024 | DC | 68 | 68 | null | M | null | VACCINE FROZEN INSTEAD OF REFRIGERATED | null | null | null | null | null | null | null | null | null | 07/22/2021 | 07/22/2021 | 0 | null | PUB | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,165 | 01/02/2024 | MI | 75 | 75 | null | M | null | Admit date: 12/23/2023 Discharge date: 12/27/2023 Admitting Physician: MD Attending Physician at the Time of Discharge: MD Primary Care Physician: DO FACOI Reason for Admission: Viral sepsis, neutropenic fever Hospital Course: Patient is a 78-year-old male with a past medical history of lung cancer receiving chemotherapy with Dr. paroxysmal atrial fibrillation, hypertension, hyperlipidemia, sick sinus syndrome status post pacemaker, presented to the emergency department for a syncopal episode. Patient was admitted for viral sepsis due to COVID-19 and likely postural hypotension and dizziness due to initiation terazosin at 5 mg twice daily by primary care provider for blood pressure management. Patient was placed on cefepime and remdesivir protocol. Patient did not have any evidence of hypoxia. Patient was also found to be neutropenic which resolved with granulocyte colony stimulating factor. During hospital course, patient was also found to have worsening thrombocytopenia where in 1 unit of platelets was transfused with improvement. Patient will need to follow up with heme Onc for pancytopenia and continued treatments for lung cancer. Patient will also need to follow up with primary care provider for blood pressure management. Blood pressure is inpatient were acceptable, advised patient to keep a blood pressure log and if an additional agent is needed, we do suggest starting an alternative medication other than terazosin such as amlodipine. Discharged on Augmentin and ciprofloxacin to complete course for neutropenic fever. Discharged to home. | null | null | null | null | Y | 4 | null | null | null | 03/24/2021 | 12/23/2023 | 1,004 | null | PVT | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,166 | 01/02/2024 | PR | 21 | 21 | null | F | null | null | null | null | null | null | null | null | null | null | Y | 11/02/2021 | 11/02/2021 | 0 | null | PVT | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,167 | 01/02/2024 | MI | 60 | 60 | null | F | null | Admit date: 12/27/2023 Discharge date: 12/29/2023 Reason for Admission: Coughing, SOB Brief Summary of Hospital Stay: PT. is a 63 YO female who presents with cough, SOB. She has relevant medical history of dysphagia, tobacco abuse, chronic obstructive pulmonary disease (?), schizophrenia. On presentation patient stable with symptoms of coughing "until blue in the face" and/or until she threw up. Tested positive for COVID on admission, blood cultures negative. CXR with R hemidiaphragm elevation, R lung base strandy opacifications. Mild leukocytosis on labs. Treated with steroids, remdesivir and symptomatic management. Oxygen weaned on 12/29 with normal walk test. Discharged in stable condition back to facility with steroid course, inhalers, symptomatic Discharged to home. | null | null | null | null | Y | 2 | null | null | null | 02/26/2021 | 12/27/2023 | 1,034 | null | PVT | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,168 | 01/02/2024 | DC | 69 | 69 | null | M | null | VACCINE FROZEN INSTEAD OF REFRIGERATED | null | null | null | null | null | null | null | null | null | 10/21/2021 | 10/21/2021 | 0 | null | PUB | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,169 | 01/02/2024 | NC | 27 | 27 | null | F | null | I mistakenly gave the client a Twinrix vaccine in her LD when she was immunized as a child for Hepatitis A&B. The client's husband was present at the visit and was supposed to receive that vaccine. The client was informed of the mistake. | null | null | null | null | null | null | null | null | U | 01/02/2024 | 01/02/2024 | 0 | null | PUB | null | Unknown | Unknown | None | null | null | 2 | 01/02/2024 | null | null | null | None |
2,729,170 | 01/02/2024 | null | 26 | 26 | null | F | null | null | null | null | null | null | null | null | null | null | Y | 11/02/2021 | 11/02/2021 | 0 | null | UNK | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,171 | 01/02/2024 | DC | 52 | 52 | null | M | null | VACCINE FROZWN INSTEAD OF REFRIGERATED | null | null | null | null | null | null | null | null | null | 10/14/2023 | 10/14/2023 | 0 | null | PUB | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,172 | 01/02/2024 | FL | 55 | 55 | null | F | null | She got her vaccine, and Saturday afternoon she started having a cough from her chest, not a sore throat. It got progressively more frequent Saturday night, but definitely out of the ordinary and deep. Sunday, she felt generally OK, fatigued but she worked in her yard and did some other things. By Sunday night she was starting to get sick, coughing was almost like bronchitis and really deep. She started getting a head cold situation, and just generally feeling bad, joints hurting, back hurting and her hips as well. Her arm where the injection was sore, but she expected that. By Sunday night she was just full time sick and could not move. She was in bed all day yesterday as it hurt to get out of bed, did not e anything other than a little biscuit. The coughing hurt, she had a fever this whole time that broke Sunday night and then came back yesterday. She did not measure the temp, but had chills, flu-like symptoms the entire time. She has been taking Nyquil for her symptoms. She started to get a headache yesterday afternoon and would take the Nyquil and it would go away, and then woke up with an excruciating headache and took some Advil for it. She has not called her doctor. She is feeling better today, not going to work today but feeling better than she did yesteday and able to move around some. | null | null | null | null | null | null | null | null | N | 12/29/2023 | 12/30/2023 | 1 | None. | PHM | null | Multivitamin. | Possible strept throat after Thanksgiving. | None. | shingles vaccine earlier this year, flu-like symptoms. | null | 2 | 01/02/2024 | null | null | null | None. |
2,729,173 | 01/02/2024 | FL | 16 | 16 | null | M | null | Pt developed HA the morning after the immunization. HA worsened went to nurse at school stated to develop LE weakness, facial droop. Pt taken to ED. Per mom pt was disoriented in ED, had emesis, bradycardia (30s), abnormal movements ? seizure. | null | null | Y | null | Y | 6 | null | null | Y | 12/18/2023 | 12/19/2023 | 1 | LP, MRI brain, CT brain 12/19 | PVT | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,174 | 01/02/2024 | MI | 82 | 82 | null | F | null | Admit date: 12/29/2023 Discharge date: 12/30/2023 Reason for Admission: Acute hypoxic respiratory failure due to COVID Brief Summary of Hospital Stay: 85yoF hx below presented for SOB, cough, generalized myalgia/chills, COVID+, hypoxic and dyspneic. Admitted for O2 therapy and decadron, symptoms reported to start 12/14/23 and likely has post viral bronchitis and not still virulent with covid, oxygen rapidly weaned to RA and she ambulated around the room for me with a walker without issues, requested discharge home. Will not continue steroids given no wheeze or hypoxia on discharge. Spoke to her daughter that given CDC guidelines she is no longer infectious given >10d from symptoms onset. Discharged to home. | null | null | null | null | Y | 1 | null | null | null | 04/06/2021 | 12/29/2023 | 997 | null | PVT | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,176 | 01/02/2024 | DC | 68 | 68 | null | M | null | VACCINE FROZEN INSTEAD OF REFRIGERATED | null | null | null | null | null | null | null | null | null | 11/30/2021 | 11/30/2021 | 0 | null | PUB | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,177 | 01/02/2024 | GA | 70 | 70 | null | F | null | Within 4 hours my heart converted from normal sinus rhythm (NSR) to atrial fibrillation (AF). It remained there for 2 weeks until I had a cardioversion. For the next month it was mostly NSR, with 4 episodes of AF lasting less than 24 hr. After that it converted to AF and stayed there for over 3 months until I had an ablation 12/15/23. That converted it to NSR for 48 hours and I am back in AF again. Prior to the vaccine, my AF was only intermittent and was fairly well controlled by controlling triggers. After the vaccine, it converted to constant AF without a break. | null | null | null | null | null | null | null | Y | N | 07/10/2023 | 07/10/2023 | 0 | Appointment cardiologist, 9/12/23, Cardioversion, 8/24/23, Cardiac Ablation, 12/15/23, Cardioversion, 12/19/23 | PHM | null | Flagyl | intestinal parasites | paroxysmal atrial fibrillation occurring only intermittently (brief episode of AF every week or two) | null | null | 2 | 01/02/2024 | null | Y | Y | domestic honey bee venom |
2,729,178 | 01/02/2024 | DC | 64 | 64 | null | M | null | VACCINE REFRIGERATED INSTEAD OF FROZEN | null | null | null | null | null | null | null | null | null | 07/26/2022 | 07/26/2022 | 0 | null | PUB | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,179 | 01/02/2024 | MI | 48 | 48 | null | F | null | Discharge Examination & Summary Admission Date and Time: 12/19/2023 6:46 PM Discharge Date: 12/31/2023 Admission Diagnosis: Mild traumatic brain injury Discharge Diagnosis: Mild traumatic brain injury Diagnosis ? Mass of uterine cervix ? Anemia ? Depression ? Invasive squamous cell cancer of the cervix ? Malignant neoplasm of endocervix ? Gallstones ? Mild traumatic brain injury ? SAH (subarachnoid hemorrhage) ? SDH (subdural hematoma) ? Orbit fracture, right ? Closed fracture of distal phalanx of right little finger ? Anxiety ? Constipation ? Vitamin D deficiency ? Scalp laceration ? Fracture of distal end of right humerus ? Tibia/fibula fracture, right, closed, initial encounter ? Major traumatic injury PREMORBID FUNCTIONAL STATUS Premorbid Functional Status: Level of Independence: Independent with transfers; Independent with ambulation REHABILITATION COURSE Pt. is a pleasant 50 YO right handed female with anxiety who presented 12/19/2023 6:46 PM to hospital after primary admission to Hospital for major multiple trauma after MVC. On 12/12/23, patient remembers that she was driving and then hitting a car passing perpendicularly in front of her on the side of their car. Then her car was hit from behind and then she blacked out. She remembers the EMTs but doesn't remember if in or out of ambulance. Then she remembers waking up again when they were explaining that she was being taken to hospital and then woke up again at hospital. List of injuries as follows: Right arm (distal humerus) fracture Right leg, foot (tibia, fibula) fractures Scalp lacerations Subarachnoid hemorrhage Subdural hemorrhage Right periorbital contusion and blowout fracture Right fifth distal phalanx fracture She underwent the following procedures: 12/12: Repair of scalp lacerations 12/12: Reduction of right lower extremity fracture by Orthopedic surgery 12/12: Wrist splinting of right upper extremity by Orthopedic surgery 12/12 Left great toe washout and closure 12/13: ORIF R Ankle fracture, pinning 1st and 2nd toes 12/14 - ORIF R distal humerus fracture 12/15 - ORIF R bimall ankle fx, R syndesmotic repair, gissane spike for ankle dislocation, ORIF 1st and 2nd proximal phalanx, open reduction without fixation of 4th proximal phalanx, I&D R open 1st, 2nd, 4th proximal phalanx, I&D R knee traumatic arthrotomy, closed tx w/o manipulation of R calcaneus anterior process fx, R short leg splint application Hospital course was complicated by incidental cholelithiasis which patient may follow up with PCP outpatient. She was also seen by SLP and neuropsych who found her demonstrating good cognitive recovery When medically stable, the patient was discharged for acute inpatient rehabilitation of functional and cognitive deficits. Symptoms related to these abovementioned conditions and events were well-controlled, and the patient was discharged medically stable and improved. There were no significant acute episodes that affected length of stay or tolerance to therapies. The patient was also provided orthotics / durable medical equipment to ensure improved function and safety in the rehabilitation and home setting. Occupational, Physical and Speech Language Pathology therapists and a Neuropsychologist were consulted for evaluation and treatment so as to best determine the amount and extent of services required for cognitive and functional optimization. The patient received a minimum of 180 minutes of therapy per day for 5 out of 7 days, or more than 15 hours of intensive therapy over the course of a week. While in the unit, the acute rehabilitation service also held interdisciplinary team conferences on a weekly basis to establish specific short- and long-term goals during rehabilitation, and for discharge. Barriers to discharge were also noted and updated as they were addressed. Plans to assure continuity and coordination of care after discharge from the acute rehabilitation unit were also established and explained to the patient and care provider(s). Discharged to home. | null | null | null | null | Y | 12 | null | null | null | 12/09/2021 | 12/19/2023 | 740 | null | PVT | null | null | null | null | null | null | 2 | 01/02/2024 | null | null | null | null |
2,729,180 | 01/02/2024 | NM | 2 | 2 | 0.1 | M | null | patient had no adverse reactions. As soon as med error was noticed, provider was made aware, patients parent was made aware and patient was monitored for 24-48hrs after. | null | null | null | null | null | null | null | null | Y | 12/01/2023 | 12/01/2023 | 0 | none | PUB | null | none | none | none | null | null | 2 | 01/02/2024 | null | null | null | none |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.